Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma?

PubWeight™: 0.92‹?›

🔗 View Article (PMID 11535872)

Published in Eur J Cancer Prev on August 01, 2001

Authors

J M Conchillo1, G Houben, A de Bruïne, R Stockbrügger

Author Affiliations

1: Division of Internal Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands.

Articles citing this

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy (2011) 2.64

A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol (2004) 1.29

Sequential expression of putative stem cell markers in gastric carcinogenesis. Br J Cancer (2011) 1.22

Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation. World J Gastroenterol (2003) 1.09

Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol (2012) 1.06

Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev (2015) 1.05

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch (2011) 0.99

Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia (2004) 0.97

Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. Surgery (2010) 0.94

Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer (2013) 0.91

Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer. Gastroenterol Res Pract (2013) 0.87

Diagnosis and management of high risk group for gastric cancer. Gut Liver (2015) 0.86

Genetic and molecular aspects of Helicobacter pylori in gastritis, pre- cancerous conditions and gastric adenocrcinoma. Gastroenterol Hepatol Bed Bench (2015) 0.75

Articles by these authors

Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative. Ital J Gastroenterol Hepatol (1999) 2.02

Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology (2007) 1.47

Influence of oropharyngeal flora and specimen pretreatment on the recovery of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1996) 1.45

Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition. Dig Liver Dis (2005) 1.44

Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion (2001) 1.35

Gastric morphology and function in dermatitis herpetiformis and in coeliac disease. Scand J Gastroenterol (1985) 1.12

Review article: Probiotics in gastrointestinal and liver diseases. Aliment Pharmacol Ther (2007) 1.07

Quality of health care in inflammatory bowel disease: development of a reliable questionnaire (QUOTE-IBD) and first results. Am J Gastroenterol (2001) 1.07

Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol (2003) 1.06

Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res (1994) 1.06

Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy (2011) 1.05

Antral gastrin cells and serum gastrin in achlorhydria. Scand J Gastroenterol (1977) 1.04

Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin. Am J Pathol (1978) 1.02

Pernicious anaemia and mucosal endocrine cell proliferation of the non-antral stomach. Gut (1986) 1.02

Phage display of cDNA repertoires: the pVI display system and its applications for the selection of immunogenic ligands. J Immunol Methods (1999) 0.97

Epithelial-stromal interactions in colon cancer. Int J Dev Biol (1993) 0.97

Probiotics in gastroenterology: indications and future perspectives. Scand J Gastroenterol Suppl (2003) 0.93

Ampullary carcinoid and neurofibromatosis: case report and review of the literature. Neth J Med (1994) 0.92

Evaluation of immunohistochemistry for the detection of Helicobacter pylori in gastric mucosal biopsies. J Infect (1997) 0.89

Endoscopic duodenal biopsy compared with biopsy with the Watson capsule from the upper jejunum in patients with dermatitis herpetiformis. Scand J Gastroenterol (1982) 0.87

Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth. Dig Liver Dis (2001) 0.87

Inhibition of gastric acid secretion by pirenzepine (LS 519) in man. Scand J Gastroenterol (1979) 0.85

Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi. Scand J Gastroenterol Suppl (2001) 0.83

Ultrasound of the shoulder. JBR-BTR (2007) 0.83

The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease. Scand J Gastroenterol (1979) 0.82

Influence of the amount of dietary gluten on gastrointestinal morphology and function in dermatitis herpetiformis. Hum Nutr Clin Nutr (1984) 0.82

Auto-immune atrophic gastritis in patient with dermatitis herpetiformis. Acta Derm Venereol (1976) 0.82

The use of glucagon during upper gastrointestinal endoscopy. Gastrointest Endosc (1974) 0.82

Influence of gluten-free diet on the gastric condition in dermatitis herpetiformis. Scand J Gastroenterol (1985) 0.81

Omeprazole inhibits growth of gram-positive and gram-negative bacteria including Helicobacter pylori in vitro. J Antimicrob Chemother (1996) 0.81

Malabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anaemia. Acta Med Scand (1986) 0.81

Development of gastric dysfunction in dermatitis herpetiformis. Acta Derm Venereol (1978) 0.80

[Relationship between duodenal diverticuli, gallstones and duodenal and pancreaticobiliary disorders]. Ned Tijdschr Geneeskd (1996) 0.80

Monitoring of nitrous oxide in operating rooms: identification of sources and estimation of occupational exposure. J Occup Med (1990) 0.79

Chronic atrophic gastritis. Scand J Gastroenterol Suppl (1982) 0.79

[Endoscopic assessment and control of chronic atrophic gastritis and pernicious anemia]. Z Gastroenterol (1986) 0.78

Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature. Neth J Med (1992) 0.78

Serum gastrin and atrophic gastritis in achlorhydric patients with and without pernicious anemia. Scand J Gastroenterol (1976) 0.78

Evidence for a bias toward intracellular antigens in the local humoral anti-tumor immune response of a colorectal cancer patient revealed by phage display. Int J Cancer (2001) 0.77

Assessment of orocoecal transit time by means of a hydrogen (H2) breath test as compared with a radiologic control method. Scand J Gastroenterol (1986) 0.77

Potential pitfalls in the differential diagnosis of irritable bowel syndrome. Digestion (2000) 0.77

[Postoperative gastrointestinal motility disorders. 1: Sequelae following general abdominal surgery and ulcer surgery]. Fortschr Med (1988) 0.76

Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis. Aliment Pharmacol Ther (2009) 0.76

Prevalence of gastric metaplasia in the duodenal bulb and distribution of Helicobacter pylori in the gastric mucosa. A clinical and histopathological study in 96 consecutive patients. Ital J Gastroenterol Hepatol (1998) 0.76

Patients with ankylosing spondylitis and healthy relatives do not show increased small intestinal permeability with the lactulose-mannitol test. Clin Exp Rheumatol (1993) 0.76

Ongoing gastric acid inhibition is a confounding factor in Helicobacter pylori diagnosis. Eur J Gastroenterol Hepatol (1997) 0.75

[Lambliasis: a cause of malabsorption and diarrhea?]. Dtsch Med Wochenschr (1989) 0.75

The effect of cisapride on defaecation in normal human subjects--lack of effect on faecal excretion of water, fat, and bile acids. Aliment Pharmacol Ther (1989) 0.75

[Postoperative disorders of gastrointestinal motility. 2: Status following total gastrectomy and ileum resection]. Fortschr Med (1988) 0.75

[Gastritis and cancer--medical aspects]. Lakartidningen (1978) 0.75

[Anatomic variants of the pancreatic duct system--theoretical and practical aspects]. Lakartidningen (1983) 0.75

A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers. J Pathol (1997) 0.75

Serum lipase and assessment of pancreatic function. Clin Chem (1986) 0.75

Clinical results of parietal cell vagotomy and selective vagotomy with pyloroplasty in the treatment of duodenal ulcer. Two-year follow-up of a prospective randomized study. Scand J Gastroenterol (1978) 0.75

[The vagus nerve and ulcer disease]. Fortschr Med (1986) 0.75

The effect of metoclopramide (Primperan) during gastroscopic observation of the antrum and the pylorus. Gastrointest Endosc (1974) 0.75

Spontaneous remission of dermatitis herpetiformis: dietary and gastrointestinal studies. Acta Derm Venereol (1986) 0.75

Whole-body magnetic resonance imaging: technical aspects, indications and preliminary experience. JBR-BTR (2006) 0.75

[Clinical features and secretion studies in chronic gastritis]. Lakartidningen (1978) 0.75

Influence of (calcium-)uranyl-carbonate complexation on U(VI) sorption on Ca- and Na-bentonites. Environ Sci Technol (2009) 0.75

Dynamic urinary graciloplasty in male goats: a study on histology and urethral pressures. Neurourol Urodyn (1997) 0.75

Somatostatin displayed on filamentous phage as a receptor-specific agonist. Br J Pharmacol (1998) 0.75

Helicobacter pylori and non-Helicobacter pylori bacterial flora in gastric mucosal and tumour specimens of patients with primary gastric lymphoma. Eur J Clin Invest (1997) 0.75

[Do anticholinergic drugs still have significance in the therapy of ulcer?]. Leber Magen Darm (1986) 0.75